Works matching IS 03000664 AND DT 2000 AND VI 52 AND IP 1
Results: 18
The effects of growth hormone replacement therapy on overnight metabolic fuels in hypopituitary patients.
- Published in:
- Clinical Endocrinology, 2000, v. 52, n. 1, p. 17, doi. 10.1046/j.1365-2265.2000.00862.x
- By:
- Publication type:
- Article
The insulin resistance syndrome and the binding capacity of cortisol binding globulin (CBG) in men and women.
- Published in:
- Clinical Endocrinology, 2000, v. 52, n. 1, p. 93, doi. 10.1046/j.1365-2265.2000.00864.x
- By:
- Publication type:
- Article
Leptin concentrations in Prader-Willi syndrome before and after growth hormone replacement.
- Published in:
- Clinical Endocrinology, 2000, v. 52, n. 1, p. 101, doi. 10.1046/j.1365-2265.2000.00868.x
- By:
- Publication type:
- Article
Suppression of endogenous insulin secretion by exogenous insulin in patients with insulinoma.
- Published in:
- Clinical Endocrinology, 2000, v. 52, n. 1, p. 87, doi. 10.1046/j.1365-2265.2000.00869.x
- By:
- Publication type:
- Article
Mutations in the type II 3β-hydroxysteroid dehydrogenase (HSD3B2) gene can cause premature pubarche in girls.
- Published in:
- Clinical Endocrinology, 2000, v. 52, n. 1, p. 67, doi. 10.1046/j.1365-2265.2000.00873.x
- By:
- Publication type:
- Article
Sexual dimorphism of cortisol metabolism is maintained in elderly subjects and is not oestrogen dependent.
- Published in:
- Clinical Endocrinology, 2000, v. 52, n. 1, p. 61, doi. 10.1046/j.1365-2265.2000.00874.x
- By:
- Publication type:
- Article
Circadian variation in serum free and total insulin-like growth factor (IGF)-I and IGF-II in untreated and treated acromegaly and growth hormone deficiency.
- Published in:
- Clinical Endocrinology, 2000, v. 52, n. 1, p. 25, doi. 10.1046/j.1365-2265.2000.00876.x
- By:
- Publication type:
- Article
Weight gain reverses bone turnover and restores circadian variation of bone resorption in anorexic patients.
- Published in:
- Clinical Endocrinology, 2000, v. 52, n. 1, p. 113, doi. 10.1046/j.1365-2265.2000.00879.x
- By:
- Publication type:
- Article
Absence of somatostatin receptor type 2 A mutations and gip oncogene in pituitary somatotroph adenomas.
- Published in:
- Clinical Endocrinology, 2000, v. 52, n. 1, p. 35, doi. 10.1046/j.1365-2265.2000.00880.x
- By:
- Publication type:
- Article
The prevalence of polycystic ovaries in women with type 2 diabetes mellitus.
- Published in:
- Clinical Endocrinology, 2000, v. 52, n. 1, p. 81, doi. 10.1046/j.1365-2265.2000.00884.x
- By:
- Publication type:
- Article
Endogenous inhibitors of 11β–hydroxysteroid dehydrogenase type 1 do not explain abnormal cortisol metabolism in polycystic ovary syndrome.
- Published in:
- Clinical Endocrinology, 2000, v. 52, n. 1, p. 77, doi. 10.1046/j.1365-2265.2000.00893.x
- By:
- Publication type:
- Article
Disrupted cortisol–ACTH relationships in elderly women given corticotrophin-releasing hormone two weeks after proximal femur fracture.
- Published in:
- Clinical Endocrinology, 2000, v. 52, n. 1, p. 51, doi. 10.1046/j.1365-2265.2000.00894.x
- By:
- Publication type:
- Article
CSF rhinorrhoea following treatment with dopamine agonists for massive invasive prolactinomas.
- Published in:
- Clinical Endocrinology, 2000, v. 52, n. 1, p. 43, doi. 10.1046/j.1365-2265.2000.00901.x
- By:
- Publication type:
- Article
Adrenal insufficiency as the first clinical manifestation of the primary antiphospholipid antibody syndrome.
- Published in:
- Clinical Endocrinology, 2000, v. 52, n. 1, p. 123, doi. 10.1046/j.1365-2265.2000.00903.x
- By:
- Publication type:
- Article
Deflazacort: towards selective glucocorticoid receptor modulation?
- Published in:
- Clinical Endocrinology, 2000, v. 52, n. 1, p. 13, doi. 10.1046/j.1365-2265.2000.00913.x
- By:
- Publication type:
- Article
The innate immune response and type 2 diabetes: evidence that leptin is associated with a stress-related (acute-phase) reaction.
- Published in:
- Clinical Endocrinology, 2000, v. 52, n. 1, p. 107, doi. 10.1046/j.1365-2265.2000.00921.x
- By:
- Publication type:
- Article
Circulating IGF-I and its protective role in the pathogenesis of diabetic angiopathy.
- Published in:
- Clinical Endocrinology, 2000, v. 52, n. 1, p. 1, doi. 10.1046/j.1365-2265.2000.00922.x
- By:
- Publication type:
- Article
Growth hormone, IGF-I and diabetic angiopathy revisited.
- Published in:
- Clinical Endocrinology, 2000, v. 52, n. 1, p. 11, doi. 10.1046/j.1365-2265.2000.00925.x
- By:
- Publication type:
- Article